← Back to Clinical Trials
Recruiting NCT05343130

NCT05343130 Efficacy of a Brain-Computer Interface Controlled Functional Electrical Stimulation Therapy for Spinal Cord Injury Neurorehabilitation

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05343130
Status Recruiting
Phase
Sponsor Instituto Nacional de Rehabilitacion
Condition Cervical Spinal Cord Injury
Study Type INTERVENTIONAL
Enrollment 32 participants
Start Date 2022-08-01
Primary Completion 2027-06

Trial Parameters

Condition Cervical Spinal Cord Injury
Sponsor Instituto Nacional de Rehabilitacion
Study Type INTERVENTIONAL
Phase N/A
Enrollment 32
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2022-08-01
Completion 2027-06
Interventions
Brain-Computer InterfaceSham Brain-Computer Interface

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The study's main goal is to determine the efficacy of a therapy with brain-computer interface controlled functional electrical stimulation for neurorehabilitation of spinal cord injury patients' upper limbs. For this purpose, a randomized controlled trial will be performed to compare the clinical and physiological effects of the brain-computer interface therapy with those of a sham intervention comprised by the application of functional electrical stimulation independently of brain-computer interface control.

Eligibility Criteria

Inclusion Criteria: * Spinal Cord Injury at neurological levels C6 or C7 * American Spinal Injury Association (ASIA) classification A, B, C or D * Upper limb spasticity of less or equal to +1 measured with the Modified Ashworth Scale * Time since disease onset of more than 6 months and less than 60 months * Normal or corrected to normal vision Exclusion Criteria: * Severe attention deficits * Previous diagnosis of traumatic brain injury * Previous diagnosis of peripheral nerve injury * Previous stroke diagnosis * Previous diagnosis of neurodegenerative diseases * History of fractures in upper extremities * Skin lesions * Contractures in upper extremities that hamper mobility * Excessive muscle spasms

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology